Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?

Rheumatology (Oxford). 2016 May;55(5):769-72. doi: 10.1093/rheumatology/kev411. Epub 2015 Dec 11.

Authors

Max Yates¹, Andrew Keat¹, Karl Gaffney²

Affiliations

¹ Department of Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich and.
² Department of Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich and karl.gaffney@nnuh.nhs.uk.

PMID: 26660639
DOI: 10.1093/rheumatology/kev411

No abstract available

Publication types

Editorial

MeSH terms

Antirheumatic Agents / administration & dosage*
Antirheumatic Agents / therapeutic use
Biological Products / administration & dosage*
Biological Products / therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Spondylitis, Ankylosing / drug therapy*
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antirheumatic Agents
Biological Products
Tumor Necrosis Factor-alpha